Douglas Byrd
Psychiatry · Jackson, MSNPI 1477679736
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 33.9% of the total. Reporting peaked in 2023 at $1,222 and has fallen 55.3% since, to $546 in 2025.
Across 271 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$585
- Takeda Pharmaceuticals U.S.A., Inc.$501
- Lundbeck LLC$383
- Ironshore Pharmaceuticals Inc.$345
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$215
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 111 | $1,607 |
| Otsuka America Pharmaceutical, Inc. | 33 | $585 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $501 |
| Lundbeck LLC | 17 | $383 |
| Ironshore Pharmaceuticals Inc. | 18 | $345 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $215 |
| Corium, LLC | 11 | $210 |
| Supernus Pharmaceuticals, Inc. | 8 | $157 |
| Vanda Pharmaceuticals Inc. | 6 | $154 |
| Axsome Therapeutics, Inc. | 7 | $141 |
| Teva Pharmaceuticals USA, Inc. | 6 | $111 |
| Tris Pharma Inc | 5 | $90 |
| Bausch Health US, LLC | 3 | $62 |
| Johnson & Johnson | 3 | $53 |
| Sunovion Pharmaceuticals Inc. | 5 | $45 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
| Neos Therapeutics, LP | 1 | $16 |
| Merck | 1 | $11 |
How this compares
$4,744 in reported general payments places this provider in the 85th percentile of 219 psychiatry providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 17 | $24,067 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 34 | $987 |
| Vilazodone Hcl | 13 | $963 |
| Bupropion XlBupropion Hcl | 65 | $713 |
| Olanzapine | 20 | $673 |
| Escitalopram Oxalate | 21 | $477 |
| Trazodone Hcl | 27 | $417 |
| Clonazepam | 86 | $396 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $390 |
| Bupropion Hcl SrBupropion Hcl | 18 | $279 |
| Lamotrigine | 48 | $246 |
| Lorazepam | 16 | $231 |
| Sertraline Hcl | 29 | $212 |
| Quetiapine Fumarate | 32 | $202 |
| Buspirone Hcl | 23 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,607 | $24,06717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 219 psychiatry providers in Mississippi.
Other psychiatry in Jackson
- Jon JacksonJackson$834K
- John NortonJackson$173K
- Krishan GuptaJackson$26K
- Kristen BevillJackson$12K
- Mark ResterJackson$9K
- Roy ReevesJackson$8K
- Andrew BishopJackson$6K
- Hunter McLendonJackson$5K
- Marshall BelagaJackson$5K
- Amandeep SinghJackson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.